| Nevada                                                                  | 88-0507007                                |
|-------------------------------------------------------------------------|-------------------------------------------|
| (State      or other jurisdiction ofincorporation      or organization) | (IRS      Employer Identification Number) |

| Large      accelerated filer  ¨ | Accelerated      filer   ¨ |
|------------------------------------------------|------------------------------------------------|
| Non-accelerated      filer  ¨   | Smaller      reporting company  x    |

----

| Part      I  | Financial      Information |
|--------------|----------------------------|
|         |                       |   |   |
|         |                       |   |   |
|         | Item      1.               | Financial      Statements |   |
|         |                       |   |   |
|         |                       | Consolidated      Balance Sheets (unaudited) |   |
|         |                       | June      30, 2008 and March 31, 2008 | 1 |
|         |                       |   |   |
|         |                       | Consolidated      Statements of Operations (unaudited) |   |
|         |                       |     Three      Months Ended June 30, 2008 and 2007, and |   |
|         |                       |     Inception      (May 9, 2007) through June 30, 2008 | 2 |
|         |                       |   |   |
|         |                       | Consolidated      Statements of Cash Flow (unaudited) |   |
|         |                       |     Three      Months Ended June 30, 2008 and 2007, and |   |
|         |                       |     Inception      (May 9, 2007) through June 30, 2008 | 3 |
|         |                       |   |   |
|         |                       | Notes      to Unaudited Consolidated Financial Statements | 4 |
|         |                       |   |   |
|         | Item      2.               | Management’s      Discussion and Analysis of Financial Condition and |   |
|         |                       |    Results      of Operations | 5 |
|         |                       |   |   |
|         | Item      3.               | Quantitative      and Qualitative Disclosures About Market Risk | 5 |
|         |                       |   |   |
|         | Item      4.               | Controls      and Procedures | 6 |
|         |                       |   |   |
| Part      II | Other      Information     |   |
|         |                       |   |   |
|         | Item      2.               | Unregistered      Sales of Equity Securities and Use of Proceeds | 7 |
|         |                       |   |   |
|         | Item      6.               | Exhibits | 8 |
|         |                       |   |   |

----

|                                                                       |   | June 30,    2008 |       |   | March 31,    2008 |   |
|----------------------------------------------------------------------------|--------|------------------|------------|--------|-------------------|--------|
|                                                                       |   |             |       |   |              |   |
| ASSETS                                                                     |   |             |       |   |              |   |
|                                                                       |   |             |       |   |              |   |
| Cash and cash      equivalents                                             |   | $                | 473        |   |              | $      | 1,174 |   |
| Prepaid      expenses                                                      |   |             | -          |   |              |   | 30,750 |   |
| Deferred offering      costs                                               |   |             | 11,664     |   |              |   | 12,915 |   |
| Total current      assets                                                  |   |             | 12,137     |   |              |   | 44,839 |   |
| Property and equipment,      net                                           |   |             | 4,448      |   |              |   | 4,670 |   |
| Option agreement,      net                                                 |   |             | 4,445      |   |              |   | 11,111 |   |
| Totalassets                                                                |   | $                | 21,030     |   |              | $      | 60,620 |   |
|                                                                       |   |             |       |   |              |   |   |   |
| LIABILITIES      AND SHAREHOLDERS' DEFICIT                                 |   |             |       |   |              |   |   |   |
|                                                                       |   |             |       |   |              |   |   |   |
| Current      liabilities:                                                  |   |             |       |   |              |   |   |   |
| Accounts      payable                                                      |   | $                | 75,196     |   |              | $      | 109,188 |   |
| Accounts payable – related      parties                              |   |             | 124,197    |   |              |   | 111,783 |   |
| Accrued      liabilities                                                   |   |             | 147,572    |   |              |   | 124,730 |   |
| Stock    Payable                                                           |   |             | 90,000     |   |              |   | - |   |
| Notes payable – related      parties                                 |   |             | 32,000     |   |              |   | 410,000 |   |
| Total current      liabilities                                             |   |             | 468,965    |   |              |   | 755,701 |   |
|                                                                       |   |             |       |   |              |   |   |   |
| Long Term      Liabilities                                                 |   |             |       |   |              |   |   |   |
| Convertible notes payable, net of      discount of $375,931                |   |             | 22,054     |   |              |   | - |   |
| Total      liabilities                                                     |   |             | 491,019    |   |              |   | 755,701 |   |
| Shareholders' deficit:                                                     |   |             |       |   |              |   |   |   |
| Common stock, $.001 par value, 500,000,000 shares      authorized,         |   |             |       |   |              |   |   |   |
| 42,481,993 and 42,069,533 shares      issued and outstanding, respectively |   |             | 42,482     |   |              |   | 42,069 |   |
| Additional paid-in      capital                                            |   |             | 1,520,841  |   |              |   | 999,530 |   |
| Deficit accumulated during the development      stage                      |   |             | (2,033,313 | )      |              |   | (1,736,680 | ) |
| Total shareholders’ deficit                                          |   |             | (469,989   | )      |              |   | (695,081 | ) |
| Total liabilities and      shareholders' deficit                           |   | $                | 21,030     |   |              | $      | 60,620 |   |

----

|                                                                          |   | Three Months Ended June      30, |       |   | Inception (May 9, 2007)      to |   |
|-------------------------------------------------------------------------------|--------|----------------------------------|------------|--------|---------------------------------|--------|
|                                                                          |   | 2008                             |       |   | 2007                            |   |   | June 30,    2008 |   |
|                                                                          |   |                             |       |   |                            |   |   |   |   |
| Revenue                                                                       |   | $                                | -          |   |                            | $      | - |   |   | $ | - |   |
|                                                                          |   |                             |       |   |                            |   |   |   |   |   |   |   |
| Costs and      expenses:                                                      |   |                             |       |   |                            |   |   |   |   |   |   |   |
|     Compensation      and related expenses                |   |                             | 51,800     |   |                            |   | 125,603 |   |   |   | 779,245 |   |
|     Office      administration                            |   |                             | 2,928      |   |                            |   | 200 |   |   |   | 16,287 |   |
|     Professional      fees                                |   |                             | 165,128    |   |                            |   | 12,444 |   |   |   | 439,763 |   |
|     Investor      relations                               |   |                             | 8,360      |   |                            |   | 549 |   |   |   | 280,864 |   |
|     Merger      expenses                                  |   |                             | -          |   |                            |   | 8,113 |   |   |   | 8,113 |   |
|     Impairment      of license agreement                  |   |                             | -          |   |                            |   | 80,100 |   |   |   | 80,100 |   |
|     Acquisition      costs of subsidiary                  |   |                             | -          |   |                            |   | - |   |   |   | 220,000 |   |
|     Depreciation      and amortization                    |   |                             | 6,888      |   |                            |   | - |   |   |   | 16,252 |   |
|     Other      expenses                                   |   |                             | 31,964     |   |                            |   | 23,269 |   |   |   | 137,303 |   |
|         Total      costs and expenses |   |                             | 267,068    |   |                            |   | 250,278 |   |   |   | 1,977,927 |   |
| Interest      expense                                                         |   |                             | 29,565     |   |                            |   | 4,663 |   |   |   | 55,386 |   |
| Net loss                                                                      |   | $                                | (296,633   | )      |                            | $      | (254,941 | ) |   | $ | (2,033,313 | ) |
|                                                                          |   |                             |       |   |                            |   |   |   |   |   |   |   |
| Net loss per      share:                                                      |   |                             |       |   |                            |   |   |   |   |   |   |   |
|     Basic and      diluted                                |   | $                                | (0.01      | )      |                            | $      | (0.02 | ) |   |   |   |   |
|                                                                          |   |                             |       |   |                            |   |   |   |   |   |   |   |
| Weighted average number of common      shares outstanding - Basic and diluted |   |                             | 42,332,533 |   |                            |   | 11,719,875 |   |   |   |   |   |

----

|                                                                                                                  |   |  Three Months Ended June      30, |     |   |   |   |
|-----------------------------------------------------------------------------------------------------------------------|--------|----------------------------------------|----------|--------|--------|--------|
|                                                                                                                  |   | 2008                                   |     |   | 2007   |   |   | Cumulative from Inception      (February 9, 2007) through June 30, 2008 |   |
| Cash flows from operating      activities:                                                                            |   |                                   |     |   |   |   |   |   |   |
|     Net      loss                                                                                 |   | $                                      | (296,633 | )      |   | $      | (254,941 | ) |   | $ | (2,033,313 | ) |
|     Adjustments      to reconcile net loss to cash used in operating      activities:             |   |                                   |     |   |   |   |   |   |   |   |   |   |
|         Depreciation      and amortization                                    |   |                                   | 6,888    |   |   |   | - |   |   |   | 16,252 |   |
|         Amortization      of deferred financing costs                         |   |                                   | 1,251    |   |   |   | - |   |   |   | 3,336 |   |
|         Non-cash compensation expense      relating to license agreement      |   |                                   | -        |   |   |   | 119,900 |   |   |   | 119,900 |   |
|         Impairment      of license agreement                                  |   |                                   | -        |   |   |   | 80,100 |   |   |   | 80,100 |   |
|         Beneficial      conversion cost on convertible notes                  |   |                                   | 22,054   |   |   |   | - |   |   |   | 22,054 |   |
|         Share-based      compensation                                         |   |                                   | 58,750   |   |   |   | 880 |   |   |   | 653,161 |   |
|         Non-cash      acquisition costs of subsidiary                         |   |                                   | -        |   |   |   | - |   |   |   | 220,000 |   |
|         Changes      in assets and liabilities:                               |   |                                   |     |   |   |   |   |   |   |   |   |   |
|             Other      current assets                     |   |                                   | -        |   |   |   | - |   |   |   | (15,000 | ) |
|             Accounts      payable                         |   |                                   | (5,491   | )      |   |   | 4,440 |   |   |   | 103,697 |   |
|             Accounts      payable – related parties |   |                                   | 12,414   |   |   |   | 27,155 |   |   |   | 124,197 |   |
|             Accrued      liabilities                      |   |                                   | 42,827   |   |   |   | 10,045 |   |   |   | 167,557 |   |
| Net cash used in operating      activities                                                                            |   |                                   | (157,940 | )      |   |   | (12,421 | ) |   |   | (538,058 | ) |
| Cash flows from investing      activities:                                                                            |   |                                   |     |   |   |   |   |   |   |   |   |   |
|     Investment      in option agreement                                                           |   |                                   | -        |   |   |   | - |   |   |   | (20,000 | ) |
|     Property      and equipment                                                                   |   |                                   | -        |   |   |   | - |   |   |   | (5,145 | ) |
| Net cash used in investing      activities                                                                            |   |                                   | -        |   |   |   | - |   |   |   | (25,145 | ) |
| Cash flows from financing      activities:                                                                            |   |                                   |     |   |   |   |   |   |   |   |   |   |
|     Proceeds      from notes payable – related parties                                      |   |                                   | -        |   |   |   | 20,000 |   |   |   | 223,000 |   |
|     Repayment      of notes payable – related party                                         |   |                                   | -        |   |   |   | - |   |   |   | (13,000 | ) |
|     Proceeds      from sale of common stock                                                       |   |                                   | 90,000   |   |   |   | 1,165 |   |   |   | 91,165 |   |
|     Proceeds      from exercise of stock options                                                  |   |                                   | 67,239   |   |   |   | - |   |   |   | 270,048 |   |
| Net cash provided by financing      activities                                                                        |   |                                   | 157,239  |   |   |   | 21,165 |   |   |   | 571,213 |   |
| Net change in cash                                                                                               |   |                                   | (701     | )      |   |   | 8,744 |   |   |   | 473 |   |
| Cash and cash equivalents,      beginning of period                                                                   |   |                                   | 1,174    |   |   |   | - |   |   |   | - |   |
| Cash and cash equivalents, end of      period                                                                         |   | $                                      | 473      |   |   | $      | 8,744 |   |   | $ | 473 |   |
|                                                                                                                  |   |                                   |     |   |   |   |   |   |   |   |   |   |
| Supplemental      disclosures:                                                                                        |   |                                   |     |   |   |   |   |   |   |   |   |   |
|     Interest      paid                                                                            |   | $                                      | -        |   |   | $      | - |   |   | $ | 3,834 |   |
|     Income      taxes paid                                                                        |   | $                                      | -        |   |   | $      | - |   |   | $ | - |   |
|                                                                                                                  |   |                                   |     |   |   |   |   |   |   |   |   |   |
| Non-cash financing      activities:                                                                                   |   |                                   |     |   |   |   |   |   |   |   |   |   |
| Discount on convertible      notes                                                                                    |   |                                   | 397,985  |   |   |   |   |   |   |   | 397,985 |   |
| Stock issued for accounts      payable                                                                                |   |                                   | 28,500   |   |   |   |   |   |   |   | 28,500 |   |
|     Cancellation      of stock certificate                                                        |   | $                                      | -        |   |   | $      | - |   |   | $ | 300 |   |
|     Issuance      of note payable for license agreement                                           |   | $                                      | 200,000  |   |   | $      | 200,000 |   |   | $ | 200,000 |   |
|     Stock      issued for prepaid investor relation services                                      |   | $                                      | -        |   |   | $      | - |   |   | $ | 73,800 |   |

----

|                                                   | Before      1:80Reverse      Split | After      1:80Reverse      Split |
|--------------------------------------------------------|------------------------------------|-----------------------------------|
| Common      shares outstanding prior to reverse merger | 49,946,724                         | 624,334                           |
| Initial      shares issued pursuant to reverse merger  | 450,053,276                        | 5,625,666                         |
| Shares      issued subsequent to shareholder meeting   | 2,757,786,724                      | 34,472,334                        |
| Total      shares outstanding                          | 3,257,786,724                      | 40,722,334                        |

----

| ITEM      2. | MANAGEMENTS      DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF      OPERATIONS |
|--------------|------------------------------------------------------------------------------------------------|

| ITEM      3. | QUANTITATIVE      AND QUALITATIVE DISCLOSURES ABOUT MARKETRISK |
|--------------|----------------------------------------------------------------|

----

| ITEM      4. | CONTROLS      AND PROCEDURES |
|--------------|------------------------------|

----

----

| Exhibit No. | Description                                                                                                                                                                                                                                                                              |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.1        | Agreement      and Plan of Reorganization between Dragon Gold Resources, Inc. and Secure      Voice Communications, Inc. dated May 31, 2007, filed as an exhibit to the      Company’s Annual Report on Form 10-KSB for the year ended March 31, 2007,      filed on June 6, 2007. |
| 10.2        | Edgeline      Holdings, Inc. 2007 Stock Option Plan filed as an exhibit to the Company’s      Registration Statement on Form S-8 filed on July 25,      2007.  *                                                                                                         |
| 10.3        | Employment      agreement dated May 10, 2007, with J. Leonard Ivins filed as an exhibit to      the Company’s Annual Report on Form 10-KSB for the year ended March 31,      2007, filed on June 6, 2007.  *                                                             |
| 10.4        | Investment      Agreement dated December 20, 2007, between Registrant and Dutchess Private      Equities Fund, Ltd. Filed as an exhibit to the Company’s Form 8-K dated      December 26, 2007.                                                                                    |
| 10.5        | Registration      Rights Agreement dated December 20, 2007, between Registrant and Dutchess      Private Equities Fund, Ltd. Filed as an exhibit to the Company’s Form 8-K      dated December 26, 2007.                                                                           |
| 10.6        | Amended      and Restated Articles of Incorporation filed as an exhibit to the      Company’s Definitive Information Statement dated February 15,      2008.                                                                                                                       |
| 10.7        | Amendment      to Stock Purchase Agreement with Intertech Bio, Inc.                                                                                                                                                                                                                      |
| 21.1        | Subsidiaries      of the Registrant provided herewith.                                                                                                                                                                                                                                   |
| 31.1        | Certification      of J. Leonard Ivins.  Provided herewith.                                                                                                                                                                                                                    |
| 31.2        | Certification      of Steven M. Plumb.  Provided herewith.                                                                                                                                                                                                                     |
| 32.1        | Certification      for Sarbanes-Oxley Act of J. Leonard Ivins.  Provided      Herewith.                                                                                                                                                                                        |
| 32.2        | Certification      for Sarbanes-Oxley Act of Steven M. Plumb.  Provided      Herewith.                                                                                                                                                                                         |

----

----

----

| Investor Name                                  |   |   |   |
|------------------------------------------------|--------|--------|--------|
|  Waldemar      Priebe                |   | $      | 29,673 |   |
|  Timothy      Madden                 |   | $      | 8,152  |   |
|  Ryan      Cravey                    |   | $      | 7,414  |   |
|  Houston      Pharmaceuticals, Inc.  |   | $      | 43,761 |   |

----